Sanofi (SNY) Inventory Average (2018)

Sanofi's (SNY) quarterly Inventory Average came in at $4.3 billion in Q4 2018, up 2723.43% quarter-over-quarter from $153.8 million in Q3 2018.

Sanofi (SNY) Inventory Average (2018) Analysis & Trends

Sanofi has disclosed Inventory Average across 1 years of filings, most recently posting $4.3 billion for Q4 2018.

Inventory Average for Q4 2018 came in at $4.3 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2018 was $4.3 billion (changed N/A YoY), and the FY2025 annual result was $11.0 billion, up 6.98% from the prior year.
Inventory Average came in at $4.3 billion for Q4 2018 at Sanofi, up from $153.8 million in the prior quarter.
In the past five years, Inventory Average ranged from a high of $8.3 billion in Q1 2018 to a low of $153.8 million in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory Avg. (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	8.09 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	14.14 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	14.39 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	5.00 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	6.57 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	6.21 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	1.84 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	10.66 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	2.72 Bn
10	Sanofi	63.47 Mn	-6.87 Bn	9.49 Bn	-

Download Data